Efficacy comparison of first-line treatment regimens for stage IV esophageal squamous cell carcinoma with supraclavicular lymph node metastasis: A study of the oligometastatic subtype
Fengyi Wang, Rong Yu, Wei Zhang, Dan Han, Wei Deng, Chengxin Liu, Shixuan Zhou, Yifei Wang, Chao Bai, Mingxia Shao, Chen Wang, Yifei Wang, Wei Huang · 2026
Read Efficacy comparison of first-line treatment regimens for stage IV esophageal squamous cell carcinoma with supraclavicular lymph node metastasis: A study of the oligometastatic subtype by Fengyi Wang, Rong Yu, Wei Zhang, Dan Han, Wei Deng, Chengxin Liu, Shixuan Zhou, Yifei Wang, Chao Bai, Mingxia Shao, Chen Wang, Yifei Wang, Wei Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13525269.txt.
Description
Fengyi Wang and co-authors compare three first-line treatments for advanced esophageal cancer that has spread only to the neck lymph nodes. Their 2026 study covers 484 patients treated at three major cancer centers in China between 2019 and 2024. This limited-spread subtype fares better than widely spread disease, yet the best opening strategy for it was unsettled.
The three options pair chemotherapy with immune therapy, with radiation at the same time, or with radiation after the drug pair. Records were weighted to balance the groups before outcomes were compared. Safety was tracked alongside benefit. The authors aim to give this specific subgroup an evidence-based first choice rather than a borrowed one.
Catalog record
| CREATOR | Fengyi Wang, Rong Yu, Wei Zhang, Dan Han, Wei Deng, Chengxin Liu, Shixuan Zhou, Yifei Wang, Chao Bai, Mingxia Shao, Chen Wang, Yifei Wang, Wei Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |